Piperine Attenuates Lithocholic Acid-Stimulated Interleukin-8 by Suppressing Src/EGFR and Reactive Oxygen Species in Human Colorectal Cancer Cells.

colorectal cancer interleukin-8 piperine reactive oxygen species tumor microenvironment

Journal

Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981

Informations de publication

Date de publication:
10 Mar 2022
Historique:
received: 20 01 2022
revised: 06 03 2022
accepted: 08 03 2022
entrez: 25 3 2022
pubmed: 26 3 2022
medline: 26 3 2022
Statut: epublish

Résumé

Piperine, a natural alkaloidal pungent product present in pepper plants, possesses the properties of anti-inflammatory and anti-metastasis. Lithocholic acid is a monohydroxy-5beta-cholanic acid with an alpha-hydroxy substituent at position 3; it is a secondary bile acid that plays a pivotal role in fat absorption, and has been discovered to mediate colorectal cancer (CRC) cell invasion and migration. However, the effect of piperine on angiogenesis has been poorly investigated. In the current study, we examined the role of piperine on LCA-stimulated angiogenesis by measuring interleukin-8 (IL-8) expression; moreover, we revealed the potential molecular mechanisms in CRC cells. Here, we showed that piperine inhibited LCA-stimulated endothelial EA.hy926 cell angiogenesis in a conditioned medium obtained from colorectal HCT-116 cells. Experiments with an IL-8 neutralizer showed that IL-8 present in the conditioned medium was the major angiogenic factor. Piperine inhibited LCA-stimulated ERK1/2 and AKT via the Src/EGFR-driven ROS signaling pathway in the colorectal cell line (HCT-116). Through mutagenesis and inhibitory studies, we revealed that ERK1/2 acted as an upstream signaling molecule in AP-1 activation, and AKT acted as an upstream signaling molecule in NF-κB activation, which in turn attenuated IL-8 expression. Taken together, we demonstrated that piperine blocked LCA-stimulated IL-8 expression by suppressing Src and EGFR in human CRC HCT-116 cells, thus remarkably attenuating endothelial EA.hy926 cell tube formation.

Identifiants

pubmed: 35326180
pii: antiox11030530
doi: 10.3390/antiox11030530
pmc: PMC8944659
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : the Ministry of Education, Science, and Technology (Korea)
ID : No. 2018R1D1A1B07049918

Références

J Med Food. 2015 Feb;18(2):208-15
pubmed: 25384161
Sci Rep. 2019 Feb 14;9(1):2003
pubmed: 30765814
J Immunol. 2006 Sep 1;177(5):3427-38
pubmed: 16920985
Stem Cell Res Ther. 2016 Dec 1;7(1):181
pubmed: 27908290
Biology (Basel). 2020 Sep 21;9(9):
pubmed: 32967203
Int J Oncol. 2013 Sep;43(3):868-76
pubmed: 23835612
Toxicol Appl Pharmacol. 2012 Mar 1;259(2):248-56
pubmed: 22261521
Genes Cancer. 2011 Dec;2(12):1085-96
pubmed: 22866200
World J Clin Cases. 2018 Nov 6;6(13):577-588
pubmed: 30430113
J Agric Food Chem. 2018 May 23;66(20):5139-5148
pubmed: 29672044
Oncotarget. 2017 Jan 3;8(1):967-978
pubmed: 27888615
Front Physiol. 2018 Jun 21;9:765
pubmed: 29977209
Am J Physiol Gastrointest Liver Physiol. 2016 Jan 15;310(2):G81-92
pubmed: 26608185
J Biol Chem. 2006 May 26;281(21):14948-60
pubmed: 16547009
Gastrointest Cancer Res. 2007;1(4 Suppl 2):S37-41
pubmed: 19360146
Front Pharmacol. 2015 Nov 24;6:283
pubmed: 26635612
Int J Mol Sci. 2020 May 12;21(10):
pubmed: 32408577
World J Gastroenterol. 2007 Oct 7;13(37):4996-5002
pubmed: 17854143
N Engl J Med. 2004 Jun 3;350(23):2335-42
pubmed: 15175435
Nutr Metab (Lond). 2017 Jul 4;14:43
pubmed: 28680454
Nat Rev Cancer. 2017 Aug;17(8):457-474
pubmed: 28706266
Toxicology. 2022 Jan 30;466:153062
pubmed: 34890707
Oncogene. 2007 Jan 4;26(1):1-10
pubmed: 16799638
J Cell Biochem. 2017 Sep;118(9):2958-2967
pubmed: 28247965
Biochim Biophys Acta. 2004 Dec 17;1705(2):69-89
pubmed: 15588763
Carcinogenesis. 2000 May;21(5):999-1005
pubmed: 10783324
Oncogene. 2004 Aug 26;23(39):6603-11
pubmed: 15208668
Mol Cell Biochem. 2015 Jan;398(1-2):147-56
pubmed: 25234193
Sci Rep. 2020 Jul 15;10(1):11681
pubmed: 32669593
Blood. 2003 May 15;101(10):3960-8
pubmed: 12522014
Biomed Res Int. 2013;2013:546318
pubmed: 23986907
Front Pharmacol. 2016 Oct 20;7:390
pubmed: 27812336
Biochim Biophys Acta. 1991 Dec 10;1072(2-3):129-57
pubmed: 1751545
PLoS One. 2018 Aug 31;13(8):e0198983
pubmed: 30169511
J Biol Chem. 2004 Jul 16;279(29):30175-81
pubmed: 15143062
Int J Oncol. 2015 Apr;46(4):1835-43
pubmed: 25625479
Cell Mol Life Sci. 2020 May;77(9):1745-1770
pubmed: 31690961
J Agric Food Chem. 2018 Jul 25;66(29):7663-7673
pubmed: 29945448
Genet Mol Res. 2012 Mar 14;11(1):617-27
pubmed: 22535397
Inflammation. 2015;38(3):1093-102
pubmed: 25471891
Toxicology. 2016 Jun 15;361-362:24-38
pubmed: 27393034
Cancer J. 2015 Jul-Aug;21(4):267-73
pubmed: 26222078
Mol Carcinog. 2017 Feb;56(2):664-680
pubmed: 27377703
Life Sci. 2020 Dec 15;263:118607
pubmed: 33091445
Toxicol Sci. 2006 Jul;92(1):311-20
pubmed: 16611624
Mol Biol Cell. 2010 Dec;21(23):4287-98
pubmed: 20943948
Mol Med Rep. 2018 May;17(5):6363-6370
pubmed: 29488612
Cancer Res. 2011 Nov 15;71(22):7125-34
pubmed: 21975932
J Nutr Biochem. 2013 Jan;24(1):231-9
pubmed: 22902327
Thorax. 2013 Feb;68(2):131-41
pubmed: 23099361
Oncogene. 2002 Oct 3;21(44):6740-50
pubmed: 12360401
Am J Physiol Cell Physiol. 2016 Nov 1;311(5):C777-C792
pubmed: 27558159
Cancer Res. 2007 Nov 15;67(22):10823-30
pubmed: 18006827
Toxicol Sci. 2019 Jun 1;169(2):534-542
pubmed: 30851105
Cancer Lett. 2008 Jul 18;266(1):37-52
pubmed: 18406051
Cancer Lett. 2010 Apr 1;290(1):123-8
pubmed: 19782465
Toxicol Lett. 2021 Oct 1;349:155-164
pubmed: 34171359

Auteurs

Shinan Li (S)

Research Institute of Medical Sciences, Chonnam National University Medical School, Gwangju 501-190, Korea.

Thi Thinh Nguyen (TT)

Research Institute of Medical Sciences, Chonnam National University Medical School, Gwangju 501-190, Korea.
Nanogen Pharmaceutical Biotechnology Joint Stock Company, Ho Chi Minh City 70000, Vietnam.

Trong Thuan Ung (TT)

Research Institute of Medical Sciences, Chonnam National University Medical School, Gwangju 501-190, Korea.
Nanogen Pharmaceutical Biotechnology Joint Stock Company, Ho Chi Minh City 70000, Vietnam.

Dhiraj Kumar Sah (DK)

Research Institute of Medical Sciences, Chonnam National University Medical School, Gwangju 501-190, Korea.

Seon Young Park (SY)

Research Institute of Medical Sciences, Chonnam National University Medical School, Gwangju 501-190, Korea.

Vinoth-Kumar Lakshmanan (VK)

Faculty of Clinical Research, Sri Ramachandra Institute of Higher Education and Research, Porur, Chennai, Tamil Nadu 600 116, India.

Young Do Jung (YD)

Research Institute of Medical Sciences, Chonnam National University Medical School, Gwangju 501-190, Korea.
Department of Biochemistry, Chonnam National University Medical School, Seoyang Ro 264, Hwasun 58128, Korea.

Classifications MeSH